First-line treatment of advanced non-small cell lung cancer with ALK rearrangement: state of the art and future development.
Rocco, Danilo
First-line treatment of advanced non-small cell lung cancer with ALK rearrangement: state of the art and future development. [electronic resource] - Expert review of respiratory medicine 03 2022 - 315-321 p. digital
Publication Type: Journal Article
1747-6356
10.1080/17476348.2019.1600824 doi
Carcinoma, Non-Small-Cell Lung--drug therapy
Drug Resistance, Neoplasm--genetics
Humans
Lung Neoplasms--drug therapy
Protein Kinase Inhibitors--adverse effects
Receptor Protein-Tyrosine Kinases--genetics
First-line treatment of advanced non-small cell lung cancer with ALK rearrangement: state of the art and future development. [electronic resource] - Expert review of respiratory medicine 03 2022 - 315-321 p. digital
Publication Type: Journal Article
1747-6356
10.1080/17476348.2019.1600824 doi
Carcinoma, Non-Small-Cell Lung--drug therapy
Drug Resistance, Neoplasm--genetics
Humans
Lung Neoplasms--drug therapy
Protein Kinase Inhibitors--adverse effects
Receptor Protein-Tyrosine Kinases--genetics